Could a device extend life for advanced breast cancer patients?
NCT ID NCT07227831
First seen Nov 13, 2025 · Last updated Apr 25, 2026 · Updated 23 times
Summary
This study tests a device called TheraBionic P1 in 82 people with advanced or metastatic HR-positive, HER2-negative breast cancer whose cancer has progressed after standard hormone therapy. The goal is to see if using the device can help patients live longer without their cancer getting worse. Researchers will also check how safe and tolerable the device is over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.